Gregory T. Lucier - 05 Dec 2025 Form 4 Insider Report for MARAVAI LIFESCIENCES HOLDINGS, INC. (MRVI)

Role: Director
Signature: /s/ Kurt Oreshack, by power of attorney for Gregory T. Lucier
Issuer symbol: MRVI
Transactions as of: 05 Dec 2025
Net transactions value: +$368,544
Form type: 4
Filing time: 09 Dec 2025, 16:36:29 UTC
Previous filing: 15 Oct 2025
Next filing: 10 Dec 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
LUCIER GREGORY T	Director	C/O MARAVAI LIFESCIENCES HOLDINGS, INC., 10770 WATERIDGE CIRCLE, SUITE 200, SAN DIEGO	/s/ Kurt Oreshack, by power of attorney for Gregory T. Lucier	09 Dec 2025	0001251299

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	MRVI	Class A Common Stock	Purchase	$190,446	+51,472	+93%	$3.70	106,595	05 Dec 2025	Direct	F1
transaction	MRVI	Class A Common Stock	Purchase	$178,098	+48,528	+46%	$3.67	155,123	08 Dec 2025	Direct	F2
holding	MRVI	Class A Common Stock						109,784	05 Dec 2025	By Family Partnership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.679 to $3.70, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4.
F2	The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.62 to $3.70, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.

Content

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.679 to $3.70, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4.

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.62 to $3.70, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.